|
A biopharmaceutical company dedicated to the research, development and commercialisation of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Combining expertise in biology and chemistry, UCB is a global biopharma which focuses on severe diseases. We develop and market human pharmaceutical products in 2 core therapeutic areas: Central Nervous System (CNS): epilepsy, Parkinson's disease, restless legs syndrome, fibromyalgia Immunology disorders: Crohn's disease, rheumatoid arthritis, lupus and bone loss disorders. Products: Central Nervous System - Vimpat® (lacosamide); Keppra® (levetiracetam); Neupro® (rotigotine); Nootropil® (piracetam); Metadate CD™ (methylphenidate HCl); (CII)Xyrem® Immunology - Cimzia® (certolizumab pegol); Xyzal® (levocetirizine); Zyrtec® (cetirizine); Tussionex™ (hydrocodone polistirex and chlorpheniramine polistirex) (CIII) Lortam™ Innovair®
|
http://www.ucb.com
